Cutaneous tumors may prompt further investigations that lead to the diagnosis of NF2, but skin manifestations in NF2 are much less obvious than those associated with neurofibromatosis type 1 (NF1). This evidence concerns the gene NF2 and neurofibromatosis type 1.